This increases patient convenience and treatment adherence
This decision reverses a previous ruling that placed approximately 19 peptides on the more restrictive Category 2 list, effectively banning their use in compounded medications due to potential significant safety risks. The reversal came after significant debate and legal challenges from medical providers and pharmacy groups, who argued that the FDA had not presented sufficient evidence to justify the ban
Understanding this relationship is essential for patients with fatty liver disease, as untreated B12 deficiency can lead to irreversible neurological damage and serious anaemia
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 118,99 per year only 9,92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
The most commonly affected area is the terminal ileum (ileitis or regional enteritis), but the disease frequently extends into the colon (ileocolitis)